Loomis, Sayles & Company’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-986,386
| Closed | -$12.1M | – | 896 |
|
|
2017
Q3 | $12.1M | Buy |
986,386
+103,037
| +12% | +$1.27M | 0.03% | 375 |
|
|
2017
Q2 | $14.5M | Sell |
883,349
-30,484
| -3% | -$501K | 0.03% | 328 |
|
|
2017
Q1 | $13.1M | Buy |
913,833
+75,461
| +9% | +$1.08M | 0.03% | 360 |
|
|
2016
Q4 | $11.6M | Sell |
838,372
-43,077
| -5% | -$596K | 0.03% | 401 |
|
|
2016
Q3 | $15.9M | Sell |
881,449
-192,755
| -18% | -$3.48M | 0.04% | 326 |
|
|
2016
Q2 | $15.4M | Sell |
1,074,204
-33,191
| -3% | -$476K | 0.04% | 337 |
|
|
2016
Q1 | $13.2M | Sell |
1,107,395
-3,002
| -0.3% | -$35.9K | 0.04% | 376 |
|
|
2015
Q4 | $14.8M | Buy |
+1,110,397
| New | +$14.8M | 0.04% | 358 |
|